1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Bateman Horne Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19 | Phase 2 | Completed | Bateman Horne Center | 59 | 2023-10-15 | 2025-01-22 |
Post-Acute COVID-19 Syndrome (1)
United States (1)